Your browser is no longer supported. Please, upgrade your browser.
ICU Medical, Inc.
Index- P/E41.22 EPS (ttm)5.04 Insider Own1.40% Shs Outstand21.21M Perf Week-3.40%
Market Cap4.45B Forward P/E27.03 EPS next Y7.68 Insider Trans-12.11% Shs Float17.37M Perf Month-11.87%
Income109.40M PEG2.58 EPS next Q1.64 Inst Own96.70% Short Float2.43% Perf Quarter-7.67%
Sales1.30B P/S3.44 EPS this Y-14.20% Inst Trans0.39% Short Ratio3.01 Perf Half Y5.67%
Book/sh74.95 P/B2.77 EPS next Y6.56% ROA6.10% Target Price288.67 Perf Year-3.75%
Cash/sh25.06 P/C8.29 EPS next 5Y16.00% ROE7.10% 52W Range183.39 - 282.00 Perf YTD-12.50%
Dividend- P/FCF23.78 EPS past 5Y8.10% ROI5.80% 52W High-26.36% Beta0.55
Dividend %- Quick Ratio3.90 Sales past 5Y30.00% Gross Margin37.30% 52W Low13.24% ATR7.40
Employees7900 Current Ratio5.50 Sales Q/Q5.50% Oper. Margin9.80% RSI (14)28.71 Volatility4.09% 3.19%
OptionableYes Debt/Eq0.00 EPS Q/Q23.40% Profit Margin8.40% Rel Volume0.98 Prev Close213.21
ShortableYes LT Debt/Eq0.00 EarningsNov 03 AMC Payout0.00% Avg Volume139.86K Price207.67
Recom2.00 SMA20-8.66% SMA50-10.12% SMA200-4.42% Volume137,362 Change-2.60%
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
Aug-08-19Downgrade Raymond James Strong Buy → Outperform
Oct-17-17Initiated KeyBanc Capital Mkts Sector Weight
Jun-20-17Downgrade Sidoti Buy → Neutral
Mar-11-16Initiated Gabelli & Co Buy $128
Nov-06-15Reiterated ROTH Capital Buy $124 → $130
Aug-11-15Reiterated ROTH Capital Buy $102 → $124
May-06-15Reiterated ROTH Capital Buy $96 → $102
Feb-10-15Reiterated ROTH Capital Buy $82 → $96
Nov-11-14Upgrade ROTH Capital Neutral → Buy $56 → $82
May-09-13Downgrade The Benchmark Company Buy → Hold
Sep-27-12Reiterated The Benchmark Company Buy $60 → $69
Apr-12-12Initiated The Benchmark Company Buy $60
Sep-26-11Reiterated Ticonderoga Buy $52 → $49
Oct-29-09Initiated C.K. Cooper Buy $45
Oct-08-09Initiated Roth Capital Hold $40
Mar-05-09Initiated Northland Securities Outperform
May-02-08Initiated Jesup & Lamont Buy $35
Mar-26-08Initiated Soleil Buy
Jan-19-22 09:38AM  
Jan-18-22 05:38PM  
Jan-06-22 04:30PM  
Dec-29-21 08:30AM  
Dec-13-21 07:43AM  
Dec-10-21 09:18AM  
Dec-09-21 07:38PM  
Dec-08-21 07:21AM  
Nov-03-21 09:31PM  
Oct-27-21 03:03PM  
Oct-24-21 10:48AM  
Oct-18-21 01:35PM  
Oct-13-21 08:30AM  
Sep-18-21 10:31AM  
Sep-15-21 10:40AM  
Sep-09-21 09:34AM  
Sep-08-21 04:17PM  
Sep-03-21 02:55PM  
Aug-04-21 09:01PM  
Jul-28-21 03:04PM  
Jul-15-21 08:00AM  
Jul-13-21 12:21PM  
Jul-05-21 05:08AM  
Jun-04-21 04:07AM  
May-06-21 10:31PM  
May-05-21 01:49AM  
May-02-21 05:11AM  
Apr-29-21 05:06PM  
Apr-15-21 08:00AM  
Mar-26-21 04:33AM  
Mar-18-21 08:30AM  
Feb-26-21 02:30AM  
Feb-25-21 04:05PM  
Feb-24-21 08:30AM  
Feb-18-21 04:00AM  
Feb-04-21 08:00AM  
Feb-02-21 08:15AM  
Jan-13-21 02:23AM  
Jan-05-21 07:30AM  
Dec-22-20 10:21AM  
Dec-20-20 05:30PM  
Dec-08-20 02:10AM  
Nov-08-20 08:13AM  
Nov-06-20 02:01AM  
Nov-05-20 07:20PM  
Nov-02-20 09:44AM  
Oct-15-20 07:30AM  
Oct-07-20 08:51AM  
Sep-14-20 10:53PM  
Sep-11-20 09:36AM  
Sep-08-20 07:30AM  
Aug-19-20 01:15PM  
Aug-12-20 08:30AM  
Aug-10-20 09:00PM  
Aug-07-20 08:46AM  
Aug-03-20 12:31PM  
Jul-27-20 11:23AM  
Jul-20-20 12:14PM  
Jul-15-20 07:30AM  
Jun-17-20 11:35AM  
Jun-16-20 04:18PM  
Jun-15-20 09:31AM  
Jun-10-20 01:21PM  
Jun-08-20 05:56PM  
Jun-05-20 08:44AM  
Jun-04-20 11:18AM  
Jun-03-20 04:21PM  
Jun-02-20 03:05PM  
May-28-20 04:53PM  
May-27-20 07:25PM  
May-25-20 03:00PM  
May-22-20 06:24PM  
May-21-20 04:20PM  
May-20-20 01:19PM  
May-19-20 07:00PM  
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jain VivekChairman and CEODec 30Option Exercise58.791,15968,13813,938Dec 30 04:59 PM
Jain VivekChairman and CEODec 30Sale240.001,159278,16012,779Dec 30 04:59 PM
Jain VivekChairman and CEODec 29Option Exercise58.7910,677627,70123,456Dec 30 04:59 PM
Jain VivekChairman and CEODec 29Sale240.0010,6772,562,49312,779Dec 30 04:59 PM
Jain VivekChairman and CEODec 28Option Exercise58.791649,64212,943Dec 30 04:59 PM
Jain VivekChairman and CEODec 28Sale240.0016439,36012,779Dec 30 04:59 PM
Jain VivekChairman and CEONov 03Option Exercise58.7924,0001,410,96024,779Nov 05 05:16 PM
Jain VivekChairman and CEONov 03Sale240.0024,0005,760,04612,779Nov 05 05:16 PM
SWINNEY ROBERT SDirectorSep 15Sale243.002,157524,15120,816Sep 15 05:19 PM
FINNEY ELISHA WDirectorSep 14Option Exercise101.062,424244,9694,141Sep 14 09:58 PM
LOPEZ GEORGE ADirectorSep 14Option Exercise46.5315,295711,676255,609Sep 14 06:07 PM
FINNEY ELISHA WDirectorSep 14Sale242.202,424587,0961,717Sep 14 09:58 PM
Sanzone Virginia RuthVP, General CounselSep 10Sale251.55800201,2411,605Sep 13 11:46 AM
SWINNEY ROBERT SDirectorJun 03Option Exercise41.503,000124,50027,473Jun 03 06:38 PM
SWINNEY ROBERT SDirectorJun 03Sale203.074,500913,79422,973Jun 03 06:38 PM
FINNEY ELISHA WDirectorMay 11Option Exercise0.0046801,951May 13 05:05 PM
Hoffmeister David FDirectorMay 11Option Exercise0.0046801,161May 12 02:55 PM
SWINNEY ROBERT SDirectorMay 11Option Exercise0.00468024,473May 12 01:45 PM
Greenberg David C.DirectorMay 11Option Exercise0.0046803,171May 12 01:41 PM
Abbey DonaldDirectorMay 11Option Exercise0.0046801,161May 12 02:08 PM
Sanzone Virginia RuthVP, General CounselMay 11Sale200.11983196,7072,405May 12 10:18 AM
LOPEZ GEORGE ADirectorApr 23Sale213.0013,0152,772,162886,843Apr 30 04:57 PM
LOPEZ GEORGE ADirectorApr 22Sale214.3011,9852,568,331899,858Apr 30 04:57 PM
LOPEZ GEORGE ADirectorApr 16Sale210.4810,1002,125,862911,843Apr 16 07:59 PM
LOPEZ GEORGE ADirectorApr 15Sale208.0214,9003,099,436921,943Apr 16 07:59 PM
LOPEZ GEORGE ADirectorApr 12Sale206.134,700968,803936,843Apr 12 06:24 PM
LOPEZ GEORGE ADirectorApr 09Sale203.5510,4002,116,890941,543Apr 12 06:24 PM
LOPEZ GEORGE ADirectorApr 08Sale203.649,9002,016,065951,943Apr 12 06:24 PM
LOPEZ GEORGE ADirectorApr 05Sale204.8310,2002,089,235961,843Apr 05 05:49 PM
LOPEZ GEORGE ADirectorApr 01Sale207.8814,8003,076,651972,043Apr 05 05:49 PM
SWINNEY ROBERT SDirectorMar 31Option Exercise44.821,50067,23024,005Mar 31 05:45 PM
Woolson DanielVP, GM-Infusion CapitalMar 06Option Exercise0.002,86208,790Mar 09 09:02 PM
Sanzone Virginia RuthVP, General CounselMar 06Option Exercise0.003,03904,227Mar 09 08:47 PM
Bonnell Brian MichaelChief Financial OfficerMar 06Option Exercise0.002,27203,598Mar 09 09:22 PM
Jain VivekChairman and CEOMar 06Option Exercise0.005,897013,776Mar 09 09:18 PM
Voigtlander Christian B.Chief Operating OfficerMar 06Option Exercise0.004,168011,866Mar 09 09:13 PM
McGrody Kevin JChief Accounting OfficerMar 06Option Exercise0.002,56804,014Mar 09 09:08 PM
SWINNEY ROBERT SDirectorMar 02Sale207.001,500310,50022,505Mar 02 05:07 PM
Voigtlander Christian B.Chief Operating OfficerFeb 18Option Exercise0.003,519010,949Feb 19 05:36 PM
Jain VivekChairman and CEOFeb 18Option Exercise0.008,044014,285Feb 19 05:31 PM
Woolson DanielVP, GM-Infusion CapitalFeb 18Option Exercise0.0080406,944Feb 19 05:27 PM
Sanzone Virginia RuthVP, General CounselFeb 18Option Exercise0.001,00502,502Feb 19 05:15 PM
SWINNEY ROBERT SDirectorFeb 02Option Exercise43.121,50064,68024,005Feb 02 05:01 PM